Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...
 
TPCE Banner

TPA 2018 Summer Meeting


Date: Jul 13, 2018 07:00 AM - Jul 15, 2018 01:30 AM

Fee

$0.00

CE Hours

30.00

Activity Type

  • Knowledge

Target Audience(s)

  • Pharmacists
  • Pharmacy Technicians

Accreditation(s)

Accreditation Council for Pharmacy Education
The Tennessee Pharmacists Consortium for Education is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

 

 

 

   

Objectives

  • (Pharmacists) Identify differences in the quality of health care when a health care provider becomes a patient
  • (Pharmacists) Describe possible mental hurdles for a health care provider patient
  • (Pharmacists) Identify times if/when a patient should identify themselves as a health care provider
  • (Pharmacists) List possible changes to a health care provider's practice after being a patient
  • (Pharmacy Technicians) Identify differences in the quality of health care when a health care provider becomes a patient
  • (Pharmacy Technicians) Describe possible mental hurdles for a health care provider patient
  • (Pharmacy Technicians) Identify times if/when a patient should identify themselves as a health care provider
  • (Pharmacy Technicians) List possible changes to a health care provider's practice after being a patient

Speaker(s)/Author(s)

Brian Odle, PharmD
Associate Professor, East Tennessee State University


Brief Bio : Brian Odle, PharmD received his BS from Middle Tennessee State University in 1990 and his PharmD from University of Tennessee in 1994. Dr. Odle completed a Pharmacy Practice Residency with the University of Maryland Medical System in Baltimore in 1995. Dr. Odle was the Clinical coordinator and Director of pharmacy for 2 years prior to joining the faculty at Gatton College of Pharmacy in 2007. Dr. Odle is an Associate Professor in the Department of Pharmacy Practice at Bill Gatton College of Pharmacy with East Tennessee State University. Dr. Odle maintains a clinical pharmacy practice in internal medicine/family practice at Johnson City Medical Center and Holston Valley Medical Center in addition to his teaching and scholarly activities.

Activity Number

0575-0000-18-100-L04-P/T
Date: 07/13/18
Time: 02:15 PM - 03:15 PM

CE Hours

1.00
   

   

Objectives

  • (Pharmacists) Describe the current needs and demands of the health care system.
  • (Pharmacists) Discuss current federal-level initiatives relating to pharmacy practice.
  • (Pharmacists) List specific actions that would support expansion and advancement of the pharmacy profession to improve the Nation’s health.
  • (Pharmacy Technicians) Describe the current needs and demands of the health care system.
  • (Pharmacy Technicians) Discuss current federal-level initiatives relating to pharmacy practice.
  • (Pharmacy Technicians) List specific actions that would support expansion and advancement of the pharmacy profession to improve the Nation’s health.

Speaker(s)/Author(s)

Rear Admiral Pamela M. Schweitzer, PharmD, BCACP
Assistant Surgeon General, 10th Chief Professional Officer, Pharmacy, U.S. Public Health Service


Brief Bio : On August 7, 2014, Rear Admiral (RADM) Pamela Schweitzer was appointed to be the 1st female Chief Professional Officer of Pharmacy for the United States Public Health Service (USPHS) with a temporary promotion to the Assistant Surgeon General. She received her Bachelor’s degree in Biological Sciences from California State University Fullerton (CSUF), earned her Doctor of Pharmacy from the University of California San Francisco (UCSF) School of Pharmacy, completed an Ambulatory Care/Administrative Residency at University of California Irvine Medical Center, and is a Board Certified Ambulatory Care Pharmacist (BCACP). She is currently in the Executive Master of Health Administration (EMHA) Program at the University of Southern California (USC) Sol Price School of Public Policy. Throughout her pharmacy career RADM Schweitzer has served in varied assignments, progressing in leadership responsibilities in the Indian Health Service (IHS), Veterans Administration (VA), and currently with the Centers for Medicare and Medicaid Services (CMS).

Activity Number

0575-0000-18-101-L04-P/T
Date: 07/13/18
Time: 03:20 PM - 04:20 PM

CE Hours

1.00
   

   

Objectives

  • (Pharmacists) List current national legislative issues that affect pharmacy
  • (Pharmacists) Describe current trends in community pharmacy practice
  • (Pharmacists) List current opportunities for community pharmacy practice
  • (Pharmacy Technician) List current national legislative issues that affect pharmacy
  • (Pharmacy Technician) Describe current trends in community pharmacy practice
  • (Pharmacy Technician) List current opportunities for community pharmacy practice

Speaker(s)/Author(s)

Allie Jo Shipman, PharmD
Associate Director of State Government Affairs, National Community Pharmacists Association


Brief Bio : Dr. Allie Jo Shipman is the Associate Director of State Government Affairs for the National Community Pharmacists Association (NCPA). Dr. Shipman graduated from Mercer University College of Pharmacy with her Doctor of Pharmacy and Master of Business Administration before beginning her career with NCPA. She has been an active member of APHA, and served as on the APhA- SP Member Engagement Standing Committee and Secretary General for the International Pharmaceutical Students’ Federation.

Activity Number

0575-0000-18-102-L04-P/T
Date: 07/13/18
Time: 04:25 PM - 05:25 PM

CE Hours

1.00
   

   

Activity Number

NON-ACPE
Date: 07/13/18
Time: 10:00 AM - 11:30 AM
   

 

   

Objectives

  • (Pharmacists) Describe the history of resuscitation fluids in the ICU
  • (Pharmacists) Recognize different types of resuscitation fluids
  • (Pharmacists) Discuss patient populations in which the use of balanced fluids is beneficial
  • (Pharmacists) State which patient populations further research in fluid resuscitation needs to be conducted
  • (Pharmacists) Express the next steps in implementing the utilization of balanced fluids
  • (Pharmacy Technicians) State the history of resuscitation fluids in the ICU
  • (Pharmacy Technicians) Describe the difference between colloids and crystalloids
  • (Pharmacy Technicians) Recognize differences between balanced fluids and normal saline

Speaker(s)/Author(s)

Joanna Stollings, PharmD, FCCM, FCCP
Clinical Pharmacy Specialist, Vanderbilt University Medical Intensive Care Unit


Brief Bio : Dr. Joanna L. Stollings is the Medical Intensive Care Unit Clinical Pharmacy Specialist at the Vanderbilt University Medical Center, Nashville, Tennessee. Dr. Stollings is the pharmacist for the Vanderbilt University Medical Center Post ICU Recovery Center and Delirium and Cognitive Impairment Study Group. She also is affiliate pharmacy faculty at Belmont University College of Pharmacy, Lipscomb University College of Pharmacy, and University of Tennessee College of Pharmacy. She received her PharmD from West Virginia University School of Pharmacy. She then completed a Pharmacy Practice Residency at Charleston Area Medical Center in Charleston, West Virginia and a Critical Care Pharmacy Residency at Mayo Clinic in Rochester, Minnesota. Dr. Stollings’s research interests include pharmacotherapy of agents used for analgesia, sedation, and delirium, non-pharmacologic methods used in the prevention of delirium, strategies to facilitate ventilator weaning, post intensive care syndrome, vasoactive agents, and fluids. Dr. Stollings has written over 40 research manuscripts, review articles, and book chapters on these topics. Dr. Stollings is also an active member of American College of Clinical Pharmacy and the Society of Critical Care Medicine.

Activity Number

0575-0000-18-103-L01-P/T
Date: 07/14/18
Time: 08:00 AM - 09:00 AM

CE Hours

1.00
   

   

Objectives

  • (Pharmacist) Describe the basic pathophysiology and principles of treating status epilepticus (SE)
  • (Pharmacist) Identify the pharmacologic options for the management of SE
  • (Pharmacist) Review the continuous infusions for refractory status epilepticus (RSE)
  • (Pharmacist) Summarize an algorithm for the treatment of status epilepticus in complex patients
  • (Pharmacy Technician) Define status epilepticus (SE)
  • (Pharmacy Technician) Identify the pharmacologic options for the management of SE
  • (Pharmacy Technician) Describe the importance of timely preparation of pharmacologic agents used in SE

Speaker(s)/Author(s)

Karen Berger, PharmD, BCPS, BCCCP
Neurocritical Care Clinical Pharmacist, New York-Presbyterian Hospital/Weill Cornell Medic


Brief Bio : Dr. Karen Berger is a neurocritical care clinical pharmacist at New York-Presbyterian Hospital, Weill Cornell Medical Center. She received her doctor of pharmacy from the University of Florida and went on to complete her PGY1 pharmacy residency at Yale-New Haven Hospital and her PGY2 critical care residency at the University of Illinois Medical Center at Chicago, where she acted as chief resident. Within ASHP, Dr. Berger has served on the New Practitioner’s Forum Science and Research Advisory Group, the New Practitioner’s Forum Executive Committee, Council on Therapeutics, and currently serves on the SCSS Educational Steering Committee. Within SCCM, she is a member-at-large for the Clinical Pharmacy and Pharmacology Section and the Co-Vice Chair of the Adult Item Writing Committee. She has also been an active member of the New York State Council of Health-system Pharmacists, currently serving as the Chair of the Education Committee and Immediate Past President of the NYC chapter. She is the Co-Chair of the student advisory committee at NYPH as well as a preceptor to pharmacy students and residents in the neurosciences intensive care unit.

Activity Number

0575-0000-18-104-L01-P/T
Date: 07/14/18
Time: 09:05 AM - 10:05 AM

CE Hours

1.00
   

   

Objectives

  • (Pharmacists) Define pharmacogenetics and related terms
  • (Pharmacists) List examples of gene/drug pairs with strong evidence related to pharmacogenetic variation
  • (Pharmacists) Identify multiple resources to help interpret pharmacogenetic results
  • (Pharmacy Technicians) Define pharmacogenetics and related terms
  • (Pharmacy Technicians) Describe the current focus of pharmacogenetics to enhance medication therapy management
  • (Pharmacy Technicians) Summarize the advantages and disadvantages of using pharmacogenetic tests in routine care

Speaker(s)/Author(s)

Gillian Bell, PharmD
Interim Director, Personalized Medicine, Mission Health


Brief Bio : Gillian Bell is a clinical pharmacist in the Mission Personalized Medicine Program and Assistant Professor of Clinical Education in the Division of Practice Advancement and Clinical Education at the UNC Eshelman School of Pharmacy. She completed her Doctor of Pharmacy degree at the University of Tennessee College of Pharmacy and two years of post-graduate training in Clinical Pharmacy and Clinical Pharmacogenetics at the Memphis VAMC and St. Jude Children’s Research Hospital, respectively. At Mission Health, she is focused on the use of pharmacogenetics in routine health care to help optimize the efficacy and safety of drug therapy. This includes helping providers with interpretation and application of pharmacogenetic test results in clinical care, counseling patients about these results and how they affect current and future medication therapy, and educating clinicians and patients through workshops and community presentations. She serves as a member of numerous national and international working groups focusing on implementation of pharmacogenetics in clinical care.

Activity Number

0575-0000-18-105-L01-P/T
Date: 07/14/18
Time: 10:20 AM - 11:20 AM

CE Hours

1.00
   

   

Objectives

  • (Pharmacists) Summarize the history of corticosteroid use in critically ill patients
  • (Pharmacists) Discuss the current Surviving Sepsis Guidelines statement regarding steroids in septic shock
  • (Pharmacists) Review between the trials evaluating steroids in septic shock
  • (Pharmacists) Describe the impact of the ADRENAL/APROCCHSS trials on the future use of steroids
  • (Pharmacists) Outline a treatment plan for use of steroids in critically ill patients
  • (Pharmacy Technicians) Identify the different therapies used for critically ill patients in refractory septic shock
  • (Pharmacy Technicians) List the trials evaluating steroid use in septic shock
  • (Pharmacy Technicians) Recognize the currently recommended steroid therapy for septic shock
  • (Pharmacy Technicians) Explain the results of the ADRENAL/APROCCHSS trials
  • (Pharmacy Technicians) State the use of steroids in critically ill patients in septic shock

Speaker(s)/Author(s)

Joseph M. Swanson, PharmD, FCCM, BCPS
Associate Professor, University of Tennessee Health Science Center


Brief Bio : Joseph M. Swanson is an associate professor of clinical pharmacy and translational science and an associate professor of pharmacology at the University of Tennessee College of Pharmacy and College of Medicine, respectively, in Memphis, Tennessee. Dr. Swanson received his Pharm.D. degree from the University of Tennessee in 2002. In 2003, he completed an American Society of Health-System Pharmacists (ASHP)-accredited pharmacy practice residency at the Regional Medical Center in Memphis, Tennessee. He furthered his training with a 1-year critical care/nutrition support specialty residency at the Elvis Presley Trauma Center in Memphis, Tennessee, and a 2-year critical care fellowship at the University of Tennessee. In 2006, Dr. Swanson joined the faculty at the University of Tennessee. Dr. Swanson has more than 40 peer-reviewed publications and 6 first-edition book chapters. His research interests include pharmacotherapy and infectious complications in critically ill patients, and he has served as the principal or coinvestigator for research funded through ASHP, the Society of Infectious Diseases Pharmacists, and the pharmaceutical industry. Dr. Swanson has given lectures related to critical care and infectious diseases at local, regional, and national meetings. He has been board certified in pharmacotherapy since 2005. He currently maintains a clinical practice at the level 1 trauma center (Elvis Presley Trauma Center) at Regional One Health in Memphis, Tennessee. He lectures to pharmacy students throughout the curriculum and is a preceptor in the trauma critical care APPEs.

Activity Number

0575-0000-18-106-L01-P/T
Date: 07/14/18
Time: 01:00 PM - 02:00 PM

CE Hours

1.00
   

   

Objectives

  • (Pharmacists) Discuss HIV prevalence
  • (Pharmacists) Describe the HIV life cycle and where select classes of medicine exert therapeutic activity
  • (Pharmacists) Review antiretroviral therapy (ART)
  • (Pharmacists) Identify pertinent drug-drug interactions
  • (Pharmacists) Review evidence-based medicine to select ART for patients
  • (Pharmacy Technicians) Discuss different ART classes
  • (Pharmacy Technicians) Identify appropriate ART to avoid duplication of therapy
  • (Pharmacy Technicians) Identify pertinent drug-drug interactions

Speaker(s)/Author(s)

Drew Armstrong, PharmD, BCACP, AAHIVP
HIV Clinical Pharmacist/Assistant Professor, Regional One Health/University of TN Health Scienc


Brief Bio : Dr. Drew Armstrong graduated from UTHSC College of Pharmacy in 2013 and completed his PGYI residency with a focus in ambulatory care from Regional One Health in 2014. He then went on to complete a PGY2 in Ambulatory Care from Duke University in Durham, NC in 2015. Upon completion of residency, Dr. Armstrong moved back to Memphis, TN and accepted a job at Regional One Health in the Adult Special Care Clinic as an HIV Clinical Pharmacist. Drew Armstrong is an Assistant Professor at UTHSC College of Pharmacy and precepts 3rd and 4th year pharmacy students on Ambulatory Care APPE rotations. Dr. Armstrong also teaches HIV Therapeutics to 3rd year Union School of Pharmacy Students. Dr. Armstrong is a Board Certified Ambulatory Care Pharmacist and an HIV credentialed Pharmacist through the American Academy of HIV Medicine. Dr. Armstrong currently serves as President of the Memphis Area Pharmacist Society and is an alternate delegate representing the state of Tennessee at the ASHP House of Delegates.

Activity Number

0575-0000-18-107-L02-P/T
Date: 07/14/18
Time: 02:05 PM - 03:05 PM

CE Hours

1.00
   

   

Objectives

  • (Pharmacists) Identify indications where opioid alternatives are preferred in the literature and are found to be efficacious.
  • (Pharmacists) Recognize therapeutic uses and key points for alternative medications discussed.
  • (Pharmacists) Discuss novel uses of ketamine.
  • (Pharmacists) Review options for outpatient management.
  • (Pharmacy Technicians) Identify indications where opioid alternatives are preferred.
  • (Pharmacy Technicians) Recognize uses and key points for alternative medications discussed.
  • (Pharmacy Technicians) Review options for outpatient management.

Speaker(s)/Author(s)

Julie Bennett, PharmD, MBA, BCPS
Emergency Department Lead Pharmacist, Baptist Memorial Hospital Memphis


Brief Bio : Julie Bennett is the Emergency Department Lead Pharmacist at Baptist Memorial Hospital-Memphis. Julie graduated from University of Tennessee College of Pharmacy in 2010, then completed her PGY1 residency training at the Regional Medical Center at Memphis. She started at Baptist Memphis in 2013. In addition to her clinical duties she precepts residents and students. In 2016, Julie graduated with a Master’s of Business Administration from the University of Memphis.

Activity Number

0575-0000-18-108-L01-P/T
Date: 07/14/18
Time: 03:10 PM - 04:10 PM

CE Hours

1.00
   

   

Objectives

  • (Pharmacists) Identify the meanings of certain terms used in laws and rules.
  • (Pharmacists) Describe expectations for compliance for different license types.
  • (Pharmacists) Outline potential problem issues related to compliance in pharmacy practice.
  • (Pharmacists) Discuss corrective action plans for different types of violations.
  • (Pharmacy Technicians) Identify the meanings of certain terms used in laws and rules.
  • (Pharmacy Technicians) Describe expectations for compliance for different license types.
  • (Pharmacy Technicians) Outline potential problem issues related to compliance in pharmacy practice.
  • (Pharmacy Technicians) Discuss corrective action plans for different types of violations.

Speaker(s)/Author(s)

Terry Grinder, DPh
Pharmacist Investigator, Tennessee Board of Pharmacy


Brief Bio : Dr. Terry Grinder began working in an independent pharmacy as a teenager. He has owned and worked in independent pharmacies for many years, in addition to working in hospitals and nursing homes. Dr. Grinder has also managed chain pharmacies, eventually becoming a district manager for parts of Tennessee, Alabama and Mississippi. He has been an investigator for the Board of Pharmacy (BOP) since 2004, working closely with DEA, FDA and law enforcement agents. Since 2004, he has served three terms as acting Executive Director of the BOP.

Activity Number

0575-0000-18-109-L03-P/T
Date: 07/14/18
Time: 08:00 AM - 09:00 AM

CE Hours

1.00
   

   

Objectives

  • (Pharmacists) Explain the pathophysiology of substance use disorders.
  • (Pharmacists) Describe the role medication plays in medication-assisted treatment.
  • (Pharmacists) Explain the pharmacist's role in medication-assisted treatment.
  • (Pharmacy Technicians) Recognize the role medication plays in medication-assisted treatment.
  • (Pharmacy Technicians) Explain the pharmacist's role in medication-assisted treatment.
  • (Pharmacy Technicians) Explain current Tennessee regulations around buprenorphine.

Speaker(s)/Author(s)

Erica Schlesinger, PharmD
Assistant Chief Pharmacist, Tennessee Department of Health and Substance Abuse


Brief Bio : Erica Schlesinger, PharmD is a graduate of the University of Tennessee Health Science Center College of Pharmacy (2017) and has worked in independent community pharmacy practice. She completed a PGY-1 residency with the Tennessee Department of Mental Health and Substance Abuse/University of Tennessee, before taking her current role as Assistant Chief Pharmacist in the Department of Mental Health and Substance Abuses Services. Dr. Schlesinger is a TN State Opioid Treatment Authority Designee and has worked on the Tennessee Nonresidential Buprenorphine Treatment Guidelines, as well as various website designs for the department. She also handles formulary management for the four regional mental health institutes in TN. Currently, she is working on training and implementation of electronic clinical records (ECR) in the four regional mental health institutes. Her current interests and career goals are centered around health policy, mental health and addiction treatment, and healthcare informatics. Dr. Schlesinger comes from a family heavily involved in various pharmacy practices, and she is excited to be a part of the ever-changing profession.

Activity Number

0575-0000-18-110-L01-P/T
Date: 07/14/18
Time: 09:05 AM - 10:05 AM

CE Hours

1.00
   

   

Objectives

  • (Pharmacists) List new and pending regulations of the Tennessee Board of Pharmacy.
  • (Pharmacists) Describe the boundaries between pharmacist and pharmacy technician responsibilities.
  • (Pharmacists) Explain how to practice safely and effectively under Board of Pharmacy and Department of Health guidelines and regulations.
  • (Pharmacy Technicians) List new and pending regulations of the Tennessee Board of Pharmacy.
  • (Pharmacy Technicians) Describe the boundaries between pharmacist and pharmacy technician responsibilities.
  • (Pharmacy Technicians) Explain how to practice safely and effectively under Board of Pharmacy and Department of Health guidelines and regulations.

Speaker(s)/Author(s)

Reginald Dilliard, DPh
Executive Director, Tennessee Board of Pharmacy


Brief Bio : Dr. Dilliard is the Executive Director of the Tennessee Board of Pharmacy. Prior to his current role, he worked as a pharmacy manager at Walgreens for almost 30 years. He was also the pharmacist and manager of Super D Drugs for more than a decade. He is currently serving a three-year term member term on the National Association of Boards of Pharmacy® (NABP®) Executive Committee (representing District 3). As a member of NABP, Dr. Dilliard served on the Association’s task forces and committees, including the Task Force on the Regulation of Pharmacist Care Services, the Task Force to Develop Recommendations to Best Reduce Medication Errors in Community Pharmacy Practice, the Committee on Law Enforcement/Legislation, and the Committee on Constitution and Bylaws. He has been an active member of the Tennessee Pharmacists Association, where he has served as president and chaired several committees. He has earned the National Community Pharmacists Association Pharmacy Leadership Award, Merck Award for Outstanding Achievement in the Profession of Pharmacy, Award of Merit from the TPA, and the Outstanding Leadership Award from the University of Tennessee. He is married to Dr. Jennifer Dilliard, who is also a pharmacist, and is the proud father of four children, one, Erica, who is completing a PGY-1 Pharmacy Residency at the Tennessee Department of Mental Health and Substance Abuse Services.

Activity Number

0575-0000-18-111-L03-P/T
Date: 07/14/18
Time: 10:20 AM - 11:20 AM

CE Hours

1.00
   

   

Objectives

  • (Pharmacists) Recognize “Closed System of Distribution” trends with regards to the diversion of controlled substances
  • (Pharmacists) Discuss practical actions that can be taken by the pharmacist to reduce misuse, abuse and diversion or controlled substances
  • (Pharmacists) Summarize DEA’s Notice of Inspections and the most common Code of Federal Violations identified in pharmacy inspections
  • (Pharmacists) Explain DEA’s “corresponding responsibility” rule and expectations for the pharmacist when dispensing controlled substances
  • (Pharmacy Technicians) Recognize “Closed System of Distribution” trends with regards to the diversion of controlled substances
  • (Pharmacy Technicians) Discuss practical actions that can be taken by the pharmacist to reduce misuse, abuse and diversion or controlled substances
  • (Pharmacy Technicians) Summarize DEA’s Notice of Inspections and the most common Code of Federal Violations identified in pharmacy inspections
  • (Pharmacy Technicians) Explain DEA’s “corresponding responsibility” rule and expectations for the pharmacist when dispensing controlled substances

Speaker(s)/Author(s)

David M. Hargroder
Diversion Program Manager, Drug Enforcement Administration


Brief Bio : Mr. David M. Hargroder began his career with the DEA in 1998. He was hired as a Diversion Investigator (DI) in New Orleans, Louisiana. He served in Jackson, Mississippi from December 1998 through March 2002. In December 2002, Mr. Hargroder was selected for the Regional DI position in La Paz, Bolivia. In this position, Mr. Hargroder was responsible for coordinating all Southern Cone DEA offices located throughout the South America Region to provide support regarding the diversion of chemicals and pharmaceuticals. In December 2005, Mr. Hargroder was selected for promotion to Staff Coordinator (SC) in DEA Headquarters, Office of Diversion Control, Chemical and Synthetic Drug Section. In addition, Mr. Hargroder was later transferred to the Pharmaceutical Section (ODP). At various times in his HQs assignment, Mr. Hargroder was designated as the Section Chief, responsible for all ODP operations. In January 2013, Mr. Hargroder was selected as the Diversion Group Supervisor (GS) for the Savannah, Georgia Resident Office and subsequently promoted to his current assignment as the Diversion Program Manager (DPM) for the Atlanta Field Division. Mr. Hargroder is responsible for the Diversion Programs in Georgia, North Carolina, and South Carolina. Mr. Hargroder supervises over 70 personnel in the Atlanta Field Division Diversion Program.

Activity Number

0575-0000-18-112-L03-P/T
Date: 07/14/18
Time: 01:00 PM - 02:00 PM

CE Hours

1.00
   

   

Objectives

  • (Pharmacists) List current challenges and opportunities in pharmacy practice in Tennessee
  • (Pharmacists) Describe current practice change models implemented across the state of Tennessee
  • (Pharmacists) Explain opportunities for pharmacists to get involved for transforming patient care
  • (Pharmacy Technicians) List current challenges and opportunities in pharmacy practice in Tennessee
  • (Pharmacy Technicians) Describe current practice change models implemented across the state of Tennessee
  • (Pharmacy Technicians) Explain opportunities for pharmacy technicians to get involved for transforming patient care

Speaker(s)/Author(s)

Micah Cost, PharmD, MS
Executive Director, Tennessee Pharmacists Association


Brief Bio : Dr. Cost works for members of the Tennessee Pharmacists Association as the Executive Director. His educational training includes a bachelor's degree from Lipscomb University, a Doctor of Pharmacy (PharmD) degree from the University of Tennessee Health Science Center College of Pharmacy, and a post-graduate Master's degree in Pharmaceutical Outcomes and Health Policy from the University of Florida College of Pharmacy. Dr. Cost has been with TPA since 2008, serving as the Executive Resident and the Director of Professional Affairs prior to accepting his current position. Dr. Cost has been fortunate to speak to many pharmacists, student pharmacists, health care providers, and other important stakeholders, on a variety of topics such as pharmacy practice innovation, legislative and regulatory issues, and professional development, among others. 

Activity Number

0575-0000-18-113-L04-P/T
Date: 07/14/18
Time: 02:05 PM - 03:05 PM

CE Hours

1.00
   

   

Objectives

  • (Pharmacists) Explain the current issues surrounding prescription drug abuse
  • (Pharmacists) Describe the new regulations related to the dispensing of opioids in Tennessee
  • (Pharmacists) Describe the differences between state and federal regulations
  • (Pharmacy Technicians) Explain the current issues surrounding prescription drug abuse
  • (Pharmacy Technicians) Describe the new regulations related to the dispensing of opioids in Tennessee
  • (Pharmacy Technicians) Describe the differences between state and federal regulations

Speaker(s)/Author(s)

Micah Cost, PharmD, MS
Executive Director, Tennessee Pharmacists Association


Brief Bio : Dr. Cost works for members of the Tennessee Pharmacists Association as the Executive Director. His educational training includes a bachelor's degree from Lipscomb University, a Doctor of Pharmacy (PharmD) degree from the University of Tennessee Health Science Center College of Pharmacy, and a post-graduate Master's degree in Pharmaceutical Outcomes and Health Policy from the University of Florida College of Pharmacy. Dr. Cost has been with TPA since 2008, serving as the Executive Resident and the Director of Professional Affairs prior to accepting his current position. Dr. Cost has been fortunate to speak to many pharmacists, student pharmacists, health care providers, and other important stakeholders, on a variety of topics such as pharmacy practice innovation, legislative and regulatory issues, and professional development, among others. 

Activity Number

0575-0000-18-114-L03-P/T
Date: 07/14/18
Time: 03:10 PM - 04:10 PM

CE Hours

1.00
   

   

Objectives

  • (Pharmacists) Identify important recent changes to the immunization schedules for adults and children in the United States.
  • (Pharmacists) Discuss the epidemiology of recent outbreaks of vaccine-preventable diseases in the United States.
  • (Pharmacists) Summarize information about the efficacy and possible adverse effects of currently available vaccines
  • (Pharmacists) List promising new vaccines in the development pipeline
  • (Pharmacy Technicians) Identify important recent changes to the immunization schedules for adults and children in the United States.
  • (Pharmacy Technicians) Discuss the epidemiology of recent outbreaks of vaccine-preventable diseases in the United States.
  • (Pharmacy Technicians) Summarize information about the efficacy and possible adverse effects of currently available vaccines
  • (Pharmacy Technicians) List promising new vaccines in the development pipeline

Speaker(s)/Author(s)

Stephan L. Foster, PharmD, FAPhA
Liaison Representative, Advisory Committee on Immunization Practices (ACIP


Brief Bio : Dr. Foster retired as a Captain from the US Public Health Service in 1998. As a strong advocate for the pharmacist's role in public health, has served as the APhA liaison representative on the CDC's Advisory Committee on Immunization Practices (ACIP) since 2001.  He is a national faculty and writer with APhA's Pharmacy-based Immunization Certificate Training Program, has been a featured speaker and author in many immunization education programs, and has personally trained thousands of pharmacists and students as immunizers. Dr. Foster retired as a professor from the University of Tennessee College of Pharmacy in 2016, however continues his consulting work in the area of vaccines.

Activity Number

0575-0000-18-115-L06-P/T
Date: 07/14/18
Time: 08:00 AM - 09:00 AM

CE Hours

1.00
   

   

Objectives

  • (Pharmacists) Apply recent changes in immunization recommendations and apply them to representative patient cases.
  • (Pharmacists) Utilize patient data to determine appropriate vaccinations and schedules using patient cases.
  • (Pharmacists) Compare methods of approaching patients regarding their immunization needs.
  • (Pharmacists) Utilize the ACIP Immunization schedule to determine patient immunization needs.
  • (Pharmacy Technicians) Utilize patient data to determine appropriate vaccinations and schedules using patient cases.
  • (Pharmacy Technicians) Compare methods of approaching patients regarding their immunization needs.
  • (Pharmacy Technicians) Utilize the ACIP Immunization schedule to determine patient immunization needs.

Speaker(s)/Author(s)

Stephan L. Foster, PharmD, FAPhA
Liaison Representative, Advisory Committee on Immunization Practices (ACIP


Brief Bio : Dr. Foster retired as a Captain from the US Public Health Service in 1998. As a strong advocate for the pharmacist's role in public health, has served as the APhA liaison representative on the CDC's Advisory Committee on Immunization Practices (ACIP) since 2001.  He is a national faculty and writer with APhA's Pharmacy-based Immunization Certificate Training Program, has been a featured speaker and author in many immunization education programs, and has personally trained thousands of pharmacists and students as immunizers. Dr. Foster retired as a professor from the University of Tennessee College of Pharmacy in 2016, however continues his consulting work in the area of vaccines.

Activity Number

0575-0000-18-116-L06-P/T
Date: 07/14/18
Time: 09:05 AM - 10:05 AM

CE Hours

1.00
   

   

Objectives

  • (Pharmacists) Identify potential bloodborne pathogens and their modes of transmission.
  • (Pharmacists) Explain the requirements for pharmacists and pharmacy technicians to comply with the Bloodborne Pathogens Standards.
  • (Pharmacists) Describe engineering and work practice controls that can help minimize exposure risks.
  • (Pharmacists) List the hepatitis B vaccination requirements for health care workers.
  • (Pharmacists) Outline the proper post-exposure response.
  • (Pharmacy Technicians) Identify potential bloodborne pathogens and their modes of transmission.
  • (Pharmacy Technicians) Explain the requirements for pharmacists and pharmacy technicians to comply with the Bloodborne Pathogens Standards.
  • (Pharmacy Technicians) Describe engineering and work practice controls that can help minimize exposure risks.
  • (Pharmacy Technicians) List the hepatitis B vaccination requirements for health care workers.
  • (Pharmacy Technicians) Outline the proper post-exposure response.

Speaker(s)/Author(s)

Stephan L. Foster, PharmD, FAPhA
Liaison Representative, Advisory Committee on Immunization Practices (ACIP


Brief Bio : Dr. Foster retired as a Captain from the US Public Health Service in 1998. As a strong advocate for the pharmacist's role in public health, has served as the APhA liaison representative on the CDC's Advisory Committee on Immunization Practices (ACIP) since 2001.  He is a national faculty and writer with APhA's Pharmacy-based Immunization Certificate Training Program, has been a featured speaker and author in many immunization education programs, and has personally trained thousands of pharmacists and students as immunizers. Dr. Foster retired as a professor from the University of Tennessee College of Pharmacy in 2016, however continues his consulting work in the area of vaccines.

Activity Number

0575-0000-18-117-L04-P/T
Date: 07/14/18
Time: 10:20 AM - 11:20 AM

CE Hours

1.00
   

   

Objectives

  • (Pharmacists) Discuss first-line pharmacotherapy options for alcohol and opioid use disorders, including dosing, monitoring, and adverse effects
  • (Pharmacists) Describe an appropriate treatment regimen for alcohol and opioid use disorder based upon patient specific factors
  • (Pharmacists) Recognize when naloxone is indicated and execute the administration of intranasal or intramuscular naloxone
  • (Pharmacy Technicians) Identify first-line pharmacotherapy options for alcohol and opioid use disorders
  • (Pharmacy Technicians) Discuss adverse effects of first line pharmacotherapy options used for alcohol and opioid use disorders State when naloxone should be utilized

Speaker(s)/Author(s)

Amber R. Douglass, PharmD, BCPS, BCPP
Clinical Pharmacy Specialist - Mental Health, Tennessee Valley Healthcare System, Murfreesboro


Brief Bio : Dr. Amber R. Douglass graduated from the University of Iowa College of Pharmacy and completed a residency with Central State Hospital and Sullivan University College of Pharmacy in Louisville, KY. She then joined faculty at Sullivan and served as an Assistant Professor with practice sites in psychiatry for 4.5 years. In 2016, Dr. Douglass moved to Nashville and began working at the VA in Murfreesboro, TN as a clinical pharmacy specialist in mental health practicing on the inpatient psychiatry units. She is a board certified pharmacotherapy specialist and psychiatric pharmacist. Dr. Douglass enjoys precepting students from 4 colleges of pharmacy as well as PGY1 and PGY2 psychiatry residents at the VA. Since joining the VA, she developed a Teaching Certificate Program for their PGY2 residents and developed/co-coordinates the Annual Preceptor Development Seminar. Dr. Douglass is actively involved in pharmacy organizations and currently serves as the Past Chair of the Resident and New Practitioner Committee for the College of Psychiatric and Neurologic Pharmacists. She sees patients with substance use disorders daily and is excited to deliver this presentation on evidence-based treatment for alcohol and opioid use disorders for the 2018 TPA Summer Meeting.

Activity Number

0575-0000-18-118-L01-P/T
Date: 07/14/18
Time: 01:00 PM - 02:00 PM

CE Hours

1.00
   

   

Objectives

  • (Pharmacists) Identify a process to adequately inform patients and prescribers of the pharmacological and therapeutic application(s) of select drugs introduced in 2017-2018
  • (Pharmacists) Discuss the role of efficacy and cost of select newly approved medications to existing agents
  • (Pharmacy Technicians) List the primary use of select drugs introduced in 2017-2018
  • (Pharmacy Technicians) Identify essential information to assist pharmacists in counseling patients on changes to the therapeutic application(s) of existing drugs and alternative therapies

Speaker(s)/Author(s)

James Wheeler, PharmD, BCPS
Assistant Professor of Clinical Pharmacy and Translational Science, University of Tennessee Health Science Center


Brief Bio : James Wheeler is an Assistant Professor of Clinical Pharmacy and Translational Science at the University of Tennessee Health Science Center, Knoxville campus. He received his BS in 2007 from the University of Tennessee, Chattanooga, and his PharmD from the University of Tennessee College of Pharmacy in 2011. He completed a Pharmacotherapy Residency at the UT Medical Center in Knoxville from 2011 to 2013. Following residency, Dr. Wheeler spent 2 years on the faculty at Wingate University School of Pharmacy in Charlotte, NC, then in July, 2015, joined the UT College of Pharmacy faculty. He teaches the drug information course for Pharm.D. students and directs continuing education activities for pharmacists, pharmacy technicians, and other healthcare professionals.

Activity Number

0575-0000-18-119-L01-P/T
Date: 07/14/18
Time: 02:05 PM - 03:05 PM

CE Hours

1.00
   

   

Objectives

  • (Pharmacists) Describe the growth of specialty pharmacy
  • (Pharmacists) Identify current trends and relevant topics in specialty pharmacy
  • (Pharmacists) Discuss recently approved medications in the specialty pharmacy arena
  • (Pharmacists) Recognize specialty pharmacy medications on the horizon
  • (Pharmacy Technicians) Describe the growth of specialty pharmacy
  • (Pharmacy Technicians) Identify current trends and relevant topics in specialty pharmacy
  • (Pharmacy Technicians) Discuss recently approved medications in the specialty pharmacy arena
  • (Pharmacy Technicians) Recognize specialty pharmacy medications on the horizon

Speaker(s)/Author(s)

Alicia B. Carver, PharmD, NCPS, CSP
Certified Specialty Pharmacist, Vanderbilt Specialty Pharmacy


Brief Bio : Dr. Alicia Carver received her Doctor of Pharmacy degree from the University of Tennessee College of Pharmacy in 2008. After graduation, she completed an ASHP-accredited PGY-1 Pharmacy Practice Residency at Fort Sanders Regional Medical Center in Knoxville, TN. She further went on to achieve Board Certification as a Pharmacotherapy Specialist and worked as a clinical pharmacist in an inpatient setting for 5 years where she served as a preceptor for both pharmacy students and residents. Dr. Carver transitioned to the specialty pharmacy arena in 2014, where she is currently employed by the Vanderbilt Specialty Pharmacy as a Certified Specialty Pharmacist. She is embedded in the Vanderbilt Digestive Disease Center, where she has the opportunity to provide comprehensive and coordinated specialty pharmacy care for Vanderbilt hepatology patients. Dr. Carver has been published in the areas of specialty pharmacy and hepatitis C. She is actively involved in local, state, and national professional organizations as well as ongoing hepatitis C research.

Activity Number

0575-0000-18-120-L01-P/T
Date: 07/14/18
Time: 03:10 PM - 04:10 PM

CE Hours

1.00
   

   

Objectives

  • (Pharmacists) Describe how Clinically Integrated Networks allow for interdependence, but cooperation, among healthcare providers to control costs and ensure quality
  • (Pharmacists) Identify a plan to implement Medication Therapy Management services for eligible patients under TennCare’s pilot program
  • (Pharmacists) Summarize how the current community pharmacy landscape is unsustainable and the steps necessary to ensure sustainability
  • (Pharmacy Technicians) Describe how Clinically Integrated Networks allow for interdependence, but cooperation, among healthcare providers to control costs and ensure quality
  • (Pharmacy Technicians) Identify a plan to implement Medication Therapy Management services for eligible patients under TennCare’s pilot program
  • (Pharmacy Technicians) Summarize how the current community pharmacy landscape is unsustainable and the steps necessary to ensure sustainability

Speaker(s)/Author(s)

Aaron Garst, PharmD
Owner, Seamless Healthcare PLLC


Brief Bio : Aaron Garst, PharmD, is the owner of Seamless Healthcare PLLC, a consulting firm specializing in pharmacist-provided services and value-based payment models. With unique experiences outside of traditional pharmacy practice, Dr. Garst has cultivated a passion to lead the pharmacy profession into new, emerging models of care. Dr. Garst graduated Suma Cum Laude from ETSU Bill Gatton College of Pharmacy in 2016 and went on to pursue an Executive Fellowship at the Tennessee Pharmacists Association. Dr. Garst currently serves as Project Manager for the CPhT pilot program and the Network Facilitator for CPESN® Tennessee.

Alan Corley, DPh
Owner, Corley's Pharmacy


Brief Bio : Alan Corley graduated from the University of Tennessee College of Pharmacy in 1977, a second generation pharmacist. Since that time he has practiced community pharmacy at Corley’s Pharmacy in Greeneville, TN, which currently operates both a retail community pharmacy and a closed-door pharmacy. Alan has served as TPA President and Treasurer, as a member and President of the Tennessee Board of Pharmacy, and as President of the UT College of Pharmacy Alumni Association. He has also served on the TennCare Pharmacy Advisory Committee for 14 years. Current community service activities include serving as the Mayor of Tusculum, TN, as a member of the Tusculum University Board of Trustees, as Chair of the Laughlin Health Care Foundation Board, and as a member of the Laughlin Hospital Board of Trustees. He also currently serves as Lead Luminary for CPESN Tennessee, and is dedicated to supporting new opportunities and roles for pharmacists in providing health care directly to patients.

Denise Pratt, DPh
CEO/Owner, First Pharmacy Services of Tennessee

Activity Number

0575-0000-18-121-L04-P/T
Date: 07/14/18
Time: 08:00 AM - 09:00 AM

CE Hours

1.00
   

   

Objectives

  • (Pharmacists) Discuss differences between recently published hypertension guidelines
  • (Pharmacists) Identify primary literature supporting the inclusion of team-based hypertension management
  • (Pharmacists) Discuss pharmacist specific literature related to hypertension
  • (Pharmacists) Identify published resources to aid in implementation of pharmacist services in hypertension management

Speaker(s)/Author(s)

Chad Gentry, PharmD, BCACP, CDE
Director of Experiential Quality Assurance, Associate Professor, Lipscomb University College of Pharmacy and Health


Brief Bio : Dr. Chad Gentry is an Associate Professor and Director of Experiential Quality Assurance at Lipscomb University College of Pharmacy and Health Sciences. He received his Doctor of Pharmacy degree from the University of Tennessee Health Science Center College of Pharmacy in 2008. He then completed a specialty residency in Primary Care through the University of Tennessee College of Pharmacy and Holston Medical Group. After residency, he spent three years at Bill Gatton College of Pharmacy at ETSU practicing in a diabetes treatment center and then a nurse-managed underserved clinic. Since joining faculty at Lipscomb, he has served patients at the Clinic at Mercury Courts, an interprofessional collaborative practice site through the Vanderbilt University Medical Center and Vanderbilt University School of Nursing. His research funding and scholarly activity is in collaboration with Vanderbilt University School of Nursing and Vanderbilt University School of Medicine with a focus in interprofessional education, interprofessional collaborative practice and medication adherence. Dr. Gentry holds Board Certification in Ambulatory Care (BCACP) as well as being a Certified Diabetes Educator (CDE). He serves on the Board of Directors for Corner to Corner, a Christian nonprofit that exists to extend hope to every corner of the community.

Activity Number

0575-0000-18-122-L01-P
Date: 07/14/18
Time: 09:05 AM - 10:05 AM

CE Hours

1.00
   

   

Objectives

  • (Pharmacists) List available resources that can be utilized to develop a collaborative practice agreement
  • (Pharmacists) Describe the elements required in a collaborative practice agreement
  • (Pharmacists) Explain current opportunities for community pharmacists to work with physicians
  • (Pharmacy Technicians) List available resources that can be utilized to develop a collaborative practice agreement
  • (Pharmacy Technicians) Describe the elements required in a collaborative practice agreement
  • (Pharmacy Technicians) Explain current opportunities for community pharmacists to work with physicians

Speaker(s)/Author(s)

Wesley Skelton, PharmD
Pharmacist, Wil Sav Drugs/Sweetwater


Brief Bio : Dr. Wesley Skelton received his Doctor of Pharmacy degree from East Tennessee State University in 2011. Wesley began working at Wil-Sav Drugs in Sweetwater in 2014. Wil-Sav Drugs offers numerous services to benefit patients including compounding, diabetes support and education, multi-dose packaging, immunizations, medication therapy management, and medication synchronization. In recent months, he has looked for new opportunities within his community to collaborate with providers. Wesley, his wife Denise, and four children reside in Cleveland, TN.

Activity Number

0575-0000-18-123-L04-P/T
Date: 07/14/18
Time: 10:20 AM - 11:20 AM

CE Hours

1.00
   

   

Objectives

  • (Pharmacists) Explain the CLIA regulations and forms needed to perform point of care testing.
  • (Pharmacists) Describe appropriate testing techniques and indications for testing.
  • (Pharmacists) Discuss how to incorporate point of care testing into practice.
  • (Pharmacists) Identify new consumer based point of care testing products.
  • (Pharmacy Technicians) Explain the CLIA regulations and forms needed to perform point of care testing.
  • (Pharmacy Technicians) Describe appropriate testing techniques and indications for testing.
  • (Pharmacy Technicians) Discuss how to incorporate point of care testing into practice.
  • (Pharmacy Technicians) Identify new consumer based point of care testing products.

Speaker(s)/Author(s)

Sarah Uroza, PharmD
Assistant Professor of Pharmacy Practice, Lipscomb University College of Pharmacy


Brief Bio : Sarah Uroza completed her pre-pharmacy course work at the University of Central Arkansas and received her Doctor of Pharmacy degree at the University of Arkansas for Medical Sciences College of Pharmacy in 2007. After graduation she went on to complete a community pharmacy residency with the University of Tennessee and Reeves-Sain Drug Store in Murfreesboro, Tenn. At Lipscomb she specializes in Medication Therapy Management, Over the Counter Products and Women’s Health. She also has an ambulatory care practice site with Faith Family Medical Clinic.

Activity Number

0575-0000-18-124-L04-P/T
Date: 07/14/18
Time: 01:00 PM - 02:00 PM

CE Hours

1.00
   

   

Objectives

  • (Pharmacists) List updates and controversies from the current diabetes management guidelines
  • (Pharmacists) Review updated treatment algorithms for the management of type 2 diabetes
  • (Pharmacists) Outline new evidence and updated management strategies for the treatment of type 2 diabetes
  • (Pharmacists) Describe the utilization of collaborative pharmacy practice in diabetes care
  • (Pharmacy Technicians) List updates and controversies from the current diabetes management guidelines
  • (Pharmacy Technicians) Review updated treatment algorithms for the management of type 2 diabetes
  • (Pharmacy Technicians) Describe the utilization of collaborative pharmacy practice in diabetes care

Speaker(s)/Author(s)

Kimberly L. Zitko, PharmD
Assistant Professor, South College of Pharmacy


Brief Bio : Dr. Kimberly L. Zitko studied at The University of Toledo where she obtained her Bachelor of Science in Pharmaceutical Sciences and Doctor of Pharmacy degrees. She completed her PGY1 Pharmacy Residency with St. Louis College of Pharmacy/Mercy Hospital St. Louis and her PGY2 Ambulatory Care Residency with St. Louis College of Pharmacy/St. Louis County Department of Public Health. She is now an Assistant Professor with South College School of Pharmacy, and she specializes in Ambulatory Care. She established her clinical practice in family medicine at Trinity Medical Associates in Knoxville, TN where she precepts student pharmacists and specializes in anticoagulation, chronic disease management and drug information for the clinic. As the first clinical pharmacist at her site, she has endeavored to advance the profession of pharmacy by implementing a collaborative pharmacy practice agreement. Her colleagues describe her as a positive and creative team member that cares deeply for her patients and students. She considers one of her most meaningful achievements to be the Resident Teaching Award she received as a product of her commitment to teaching during her PGY1 residency training. In her spare-time she enjoys baking, yoga and spending quality time with her husband and miniature dachshunds.

Activity Number

0575-0000-18-125-L01-P/T
Date: 07/14/18
Time: 02:05 PM - 03:05 PM

CE Hours

1.00
   

   

Objectives

  • (Pharmacists) List different types of alternative payment models
  • (Pharmacists) Describe the involvement of pharmacists in alternative payment models
  • (Pharmacists) Explain the opportunity for inter professional collaboration in alternative payment models
  • (Pharmacy Technicians) List different types of alternative payment models
  • (Pharmacy Technicians) Describe the involvement of pharmacists in alternative payment models
  • (Pharmacy Technicians) Explain the opportunity for inter professional collaboration in alternative payment models

Speaker(s)/Author(s)

Panel Discussion

Activity Number

0575-0000-18-126-L04-P/T
Date: 07/14/18
Time: 03:10 PM - 04:10 PM

CE Hours

1.00
   

 

   

Objectives

  • (Pharmacists) Discuss ASHP legislative advocacy initiatives, including work on shortages and provider status.
  • (Pharmacists) Describe the current ASHP regulatory work on drug pricing and compounding.
  • (Pharmacists) Summarize anticipated developments in 2018 hot topic areas such as 340B.
  • (Pharmacy Technicians) Discuss ASHP legislative advocacy initiatives, including work on shortages and provider status.
  • (Pharmacy Technicians) Describe the current ASHP regulatory work on drug pricing and compounding.
  • (Pharmacy Technicians) Summarize anticipated developments in 2018 hot topic areas such as 340B.

Speaker(s)/Author(s)

Jillanne Schulte Wall, J.D.
Director, Federal Regulatory Affairs, Government Affairs Division, American Society of Health-System Pharmacists


Brief Bio : Jillanne Schulte Wall is the Director of Federal Regulatory Affairs for the American Society of HealthSystem Pharmacists (ASHP) in Bethesda, MD. Ms. Schulte Wall serves as ASHP’s primary liaison to federal regulatory agencies and, in conjunction with other members of the Government Relations team, develops and communicates of ASHP’s positions on federal regulations and guidance related to the profession of pharmacy. Additionally, Ms. Schulte Wall works closely with stakeholders in pharmacy, medicine, manufacturing, and patient advocacy on legislative and regulatory issues of importance to ASHP members. Prior to joining ASHP, Ms. Schulte Wall was the Director of Regulatory Affairs for the American Pharmacists Association in Washington, D.C. She began her career as a healthcare attorney at Feldesman Tucker Leifer Fidell LLP in Washington, DC, where she advised healthcare clients on corporate, regulatory, and transactional issues, with a particular emphasis on optimizing performance after the implementation of the Affordable Care Act.

Activity Number

0575-0000-18-128-L04-P/T
Date: 07/15/18
Time: 10:15 AM - 11:15 AM

CE Hours

1.00
   

   

Objectives

  • (Pharmacist) Describe the mechanism of action and proposed benefits of kratom.
  • (Pharmacist) Identify the typical uses, major adverse effects and drug-interactions of curcumin (turmeric).
  • (Pharmacist) Identify the common chemicals used in e-cigarettes and their potential risk.
  • (Pharmacist) Discuss the place of Oscillococcinum in influenza therapy and how to counsel patients accordingly.
  • (Pharmacist) Identify the effects of delta-9-tetrahydrocannabinol (THC) and CBD in the endocannabinoid system and how this relates to anxiety.
  • (Pharmacist) Outline the primary literature that determines evidence for efficacy changes in levonorgestrel based on patient
  • (Pharmacy Technician) Describe the mechanism of action and proposed benefits of kratom.
  • (Pharmacy Technician) Identify the typical uses, major adverse effects and drug-interactions of curcumin (turmeric).
  • (Pharmacy Technician) Identify the common chemicals used in e-cigarettes and their potential risk.
  • (Pharmacy Technician) Discuss the place of Oscillococcinum in influenza therapy and how to counsel patients accordingly.
  • (Pharmacy Technician) Identify marijuana-based and hemp-based cannabidiol products.
  • (Pharmacy Technician) Identify patients purchasing an OTC emergency contraceptive who may need to consult with a pharmacist.

Speaker(s)/Author(s)

Erin Sherwin
Oscillococcinum for the Treatment of Influenza: Effective Treatment or Placebo Effect?, University of Tennessee Health Science Center


Brief Bio : Erin Sherwin is a rising third-year student pharmacist from Collierville, TN who attends the University of Tennessee College of Pharmacy in Memphis. Erin served as member-at-large for the Tennessee Society of Student Pharmacists (TSSP) for the past year and currently serves as a TSSP delegate. She is also an active member of Phi Delta Chi and the American Pharmacists Association Academy of Student Pharmacists (APhA-ASP). This is Erin’s first time presenting.

Jessie Hipple
Health Implications of E-ciggarette Use, Lipscomb University COP and Health Sciences


Brief Bio : Jessie Hipple is from Pittsburgh, PA and a fourth-year, dual degree PharmD/Master of Management student at Lipscomb University College of Pharmacy. Jessie is a firm believer in collaborative care and participated in the Vanderbilt Program in Interprofessional Learning (VPIL), which is a longitudinal clinic experience on an interprofessional team. She was also a part of the Vanderbilt-Lipscomb Student Hotspotting Learning Collaborative, which identifies and cares for patients with complex health conditions who are recognized as high-utilizers of care. Jessie has been an active member of numerous organizations including TSSP, APhA-ASP, Phi Lambda Sigma, and NCPA. She served as a delegate and a member-at-large for TSSP and was also the committee chair for Generation RX (APhA-ASP). Her driving passion, both personally and professionally, is learning how to effectively serve and advocate for vulnerable and underserved patients.

Lily Tran
Impact of Body Weight on the Efficacy of OTC Emergency Contraception, ETSU Bill Gatton College of Pharmacy


Brief Bio : Lily Tran is a third-year student pharmacist at East Tennessee State University (ETSU) Bill Gatton College of Pharmacy. Born in Austin, TX, she attended Baylor University and graduated with her Bachelor of Science in Biology in 2015. At ETSU, Lily is heavily involved in her college and holds various leadership positions within organizations in which she is a member. Lily currently serves as President of the American Pharmacists Association - Academy of Student Pharmacists (APhA-ASP) chapter, Treasurer of the Student Societies of Health-System Pharmacy (SSHP) chapter, and co-coordinator of the student ambassadors program. She is an active member of the Epsilon Zeta chapter of Kappa Psi Pharmaceutical Fraternity and serves as a mentor to undergraduate students in the Pre-Pharmacy Club. Outside of school, Lily works as a pharmacy intern for Walgreens Pharmacy. Her interests include interdisciplinary collaboration and research.

Maren Richards
Belmont University College of Pharmacy


Brief Bio : Maren Richards is a fourth-year student-pharmacist from Valparaiso, Indiana who attends Belmont University College of Pharmacy. She is heavily involved in the American Pharmacists Association-Academy of Student Pharmacists (APhA-ASP), having served as the Belmont University chapter president last year. Through her involvement with APhA-ASP, she was able to be active in the Tennessee Society of Student Pharmacists (TSSP), and was inducted into both Phi Lambda Sigma, as well as the Rho Chi Society. Maren wants to focus her career to practice in ambulatory care pharmacy and has a passion for advancing the profession of pharmacy through collaborative practice and innovative care models.

Megan Davis
Kratom: Natural Remedy or Harmful Opioid?, Union University College of Pharmacy


Brief Bio : Megan Davis is a fourth-year student pharmacist from Jackson, TN who attends the Union University College of Pharmacy. She is involved in a variety of pharmacy organizations and has held leadership positions within those organizations. Megan served as member-at-large for the Tennessee Society of Student Pharmacists (TSSP) for the past two years and is currently serving as TSSP delegate. She was initiated as a member of Phi Lambda Sigma last spring as a result of her leadership efforts. Megan has a strong interest in substance use disorders. She attended the American Pharmacists Association’s Institute on Alcoholism and Drug Dependencies in Salt Lake City, Utah last summer and presented a continuing education program on the topic of opioid overdose and treatment with opioid antagonists to the West Tennessee Pharmacists Association (WTPA).

Megan Gower
Curcumin: What Your Patients Should Know about Supplementation, South College School of Pharmacy


Brief Bio : Megan Gower is a third-year student pharmacist from Pittsburgh, PA who attends South College School of Pharmacy (SCSOP). She has held leadership positions in a variety of pharmacy organizations and serves as a student ambassador for her program. This will be her first year serving as a member-at-large for the Tennessee Society of Student Pharmacists (TSSP) as well as a TSSP delegate. She was initiated in Phi Lambda Sigma and Rho Chi at the end of her first year based on academic performance and leadership involvement. She is intent on pursuing a career in industry and is actively involved in establishing a new Industry Pharmacists Organization chapter while at SCSOP.

Activity Number

0575-0000-18-127-L01-P/T
Date: 07/15/18
Time: 08:00 AM - 10:00 AM

CE Hours

2.00